Xeris Biopharma Holdings, Inc. (XERS) Interest Expense USD 2020 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Xeris Biopharma Holdings, Inc. quarterly/annual Interest Expense history and growth rate from 2020 to 2024.
  • Xeris Biopharma Holdings, Inc. Interest Expense for the quarter ending March 31, 2024 was $7.03 M, a 13.1% increase year-over-year.
  • Xeris Biopharma Holdings, Inc. Interest Expense for the twelve months ending March 31, 2024 was $27.4 M, a 63.3% increase year-over-year.
  • Xeris Biopharma Holdings, Inc. annual Interest Expense for 2023 was $26.6 M, a 88.7% increase from 2022.
  • Xeris Biopharma Holdings, Inc. annual Interest Expense for 2022 was $14.1 M, a 96.4% increase from 2021.
  • Xeris Biopharma Holdings, Inc. annual Interest Expense for 2021 was $7.18 M, a 32.6% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $27.4 M $7.03 M +$816 K +13.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $26.6 M $7.02 M +$3.87 M +123% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 $22.7 M $6.85 M +$2.86 M +71.6% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $19.9 M $6.53 M +$3.08 M +89.3% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $16.8 M $6.22 M +$2.7 M +76.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $14.1 M $3.14 M +$1.35 M +75.1% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 $12.8 M $3.99 M +$2.19 M +122% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $10.6 M $3.45 M +$1.65 M +92.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $8.91 M $3.52 M +$1.73 M +96.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $7.18 M $1.8 M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-06
Q3 2021 $1.8 M -$530 K -22.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $1.8 M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $1.79 M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 $2.33 M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.